Portrait Mobile Monitoring Solution V2.0 External Evaluation
NCT ID: NCT07309809
Last Updated: 2025-12-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
NA
50 participants
INTERVENTIONAL
2026-03-31
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Continuous Monitoring with Portrait Mobile
Subjects will be monitored with the Portrait Mobile Monitoring Solution for up to 72 hours
Continuous Monitoring
Subjects will have vital signs continuously monitored for up to 72 hours with the study device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Continuous Monitoring
Subjects will have vital signs continuously monitored for up to 72 hours with the study device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participant must have the ability to understand and provide written informed consent.
3. Are being cared for in a hospital unit and are expected to remain in the unit for the duration of the study procedure.
4. Participant must be willing and able to comply with study procedures and duration.
Exclusion Criteria
2. Diagnosed with infection requiring isolation.
3. Are immunocompromised.
4. Have previously participated in this study (no subject may participate more than once).
5. Subjects with Implantable Minute Ventilation Rate Responsive Pacemakers should be excluded from respiration rate monitoring.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
GE Healthcare
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
West Middlesex University Hospital
London, England, United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SA-000173
Identifier Type: -
Identifier Source: org_study_id